Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study

被引：0
|
作者：
Sonia Zaibet
Vincent Hautefeuille
Edouard Auclin
Astrid Lièvre
David Tougeron
Mathieu Sarabi
Marine Gilabert
Julie Wasselin
Julien Edeline
Pascal Artru
Dominique Bechade
Clémence Morin
Agnes Ducoulombier
Julien Taieb
Simon Pernot
机构：
[1] Université de Paris,Department of Hepato
[2] SIRIC CARPEM Comprehensive Cancer Center,Gastroenterology and Gastrointestinal Oncology, Hôpital Européen Georges Pompidou
[3] CHU Amiens Picardie,Department of Hepato
[4] Université de Paris,Gastroenterology and Gastrointestinal Oncology
[5] SIRIC CARPEM Comprehensive Cancer Center,Department of Medical Oncology, Hôpital Européen Georges Pompidou
[6] Université de Paris,INSERM, UMR 1138, team 22, Centre de Recherche des Cordeliers
[7] CHU Rennes,Department of Gastroenterology
[8] INSERM U1242,Department of Hepato
[9] CHU Poitiers,Gastroenterology
[10] Centre Léon Bérard,Department of Medical Oncology
[11] Institut Paoli-Calmettes,Department of Medical Oncology
[12] Centre Eugène Marquis,Department of Medical Oncology
[13] Hôpital Privé Jean Mermoz,Department of Hepato
[14] Institut Bergonié,Gastroenterology
[15] Centre Antoine Lacassagne,Department of Medical Oncology
来源：
British Journal of Cancer | 2022年 / 126卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：969 / 969
相关论文
共 50 条
  • [1] Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Sonia Zaibet
    Vincent Hautefeuille
    Edouard Auclin
    Astrid Lièvre
    David Tougeron
    Mathieu Sarabi
    Marine Gilabert
    Julie Wasselin
    Julien Edeline
    Pascal Artru
    Dominique Bechade
    Clémence Morin
    Agnes Ducoulombier
    Julien Taieb
    Simon Pernot
    British Journal of Cancer, 2022, 126 : 1394 - 1400
  • [2] Gemcitabine plus Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Zaibet, Simon
    Hautefeuille, Vincent
    Auclin, Edouard
    Lievre, Astrid
    Tougeron, David
    Sarabi, Mathieu
    Gilabert, Marine
    Wasselin, Julie
    Edeline, Julien
    Artru, Pascal
    Bechade, Dominique
    Morin, Clemence
    Ducoulombier, Agnes
    Taieb, Julien
    Pernot, Simon
    BRITISH JOURNAL OF CANCER, 2022, 126 (10) : 1394 - 1400
  • [3] Gemcitabine plus nab-paclitaxel or gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: A population-based, multicenter AGEO study
    Zaibet, S.
    Hautefeuille, V.
    Auclin, E.
    Lievre, A.
    Tougeron, D.
    Sarabi, M.
    Gilabert, M.
    Wasselin, J.
    Edeline, J.
    Artru, P.
    Bechade, D.
    Morin, C.
    Taieb, J.
    Pernot, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S213 - S214
  • [4] Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study (Jan, 10.1038/s41416-022-01713-w, 2022)
    Zaibet, Sonia
    Hautefeuille, Vincent
    Auclin, Edouard
    Lievre, Astrid
    Tougeron, David
    Sarabi, Mathieu
    Gilabert, Marine
    Wasselin, Julie
    Edeline, Julien
    Artru, Pascal
    Bechade, Dominique
    Morin, Clemence
    Ducoulombier, Agnes
    Taieb, Julien
    Pernot, Simon
    BRITISH JOURNAL OF CANCER, 2022, 126 (06) : 969 - 969
  • [5] Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
    Portal, Alix
    Pernot, Simon
    Tougeron, David
    Arbaud, Claire
    Bidault, Anne Thirot
    de la Fouchardiere, Christelle
    Hammel, Pascal
    Lecomte, Thierry
    Dreanic, Johann
    Coriat, Romain
    Bachet, Jean-Baptiste
    Dubreuil, Olivier
    Marthey, Lysiane
    Dahan, Laetitia
    Tchoundjeu, Belinda
    Locher, Christophe
    Lepere, Celine
    Bonnetain, Franck
    Taieb, Julien
    BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 989 - 995
  • [6] Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
    Alix Portal
    Simon Pernot
    David Tougeron
    Claire Arbaud
    Anne Thirot Bidault
    Christelle de la Fouchardière
    Pascal Hammel
    Thierry Lecomte
    Johann Dréanic
    Romain Coriat
    Jean-Baptiste Bachet
    Olivier Dubreuil
    Lysiane Marthey
    Laetitia Dahan
    Belinda Tchoundjeu
    Christophe Locher
    Céline Lepère
    Franck Bonnetain
    Julien Taieb
    British Journal of Cancer, 2015, 113 : 989 - 995
  • [7] Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’
    Caterina Vivaldi
    Lorenzo Fornaro
    Chiara Caparello
    Alfredo Falcone
    Enrico Vasile
    British Journal of Cancer, 2016, 114 : e8 - e8
  • [8] Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
    Vivaldi, Caterina
    Fornaro, Lorenzo
    Caparello, Chiara
    Falcone, Alfredo
    Vasile, Enrico
    BRITISH JOURNAL OF CANCER, 2016, 114 (11) : e8 - e8
  • [9] Reply to the comment on ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’
    Simon Pernot
    Jean-Baptiste Bachet
    Alix Portal
    Julien Taieb
    British Journal of Cancer, 2016, 114 : e9 - e9
  • [10] Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
    Pernot, Simon
    Bachet, Jean-Baptiste
    Portal, Alix
    Taieb, Julien
    BRITISH JOURNAL OF CANCER, 2016, 114 (11) : e9 - e9
12345